PDS Biotechnology Corporation
PDSB
$0.29
-$0.01-2.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -33.67M | -33.36M | -34.50M | -34.89M | -36.60M |
| Total Depreciation and Amortization | 60.40K | 60.40K | 60.40K | 60.40K | 60.40K |
| Total Amortization of Deferred Charges | 881.50K | 1.73M | 1.55M | 1.38M | 1.99M |
| Total Other Non-Cash Items | 8.55M | 5.21M | 5.51M | 5.55M | 5.33M |
| Change in Net Operating Assets | 7.40M | 3.26M | -383.00K | -4.39M | -5.14M |
| Cash from Operations | -16.78M | -23.09M | -27.75M | -32.28M | -34.37M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | 3.25M | 18.16M | 18.16M | 19.24M | 19.24M |
| Total Debt Repaid | -23.15M | -24.10M | -25.73M | -27.00M | -26.00M |
| Issuance of Common Stock | 6.15M | 7.52M | 13.98M | 13.33M | 12.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.25M | 3.19M | 6.35M | 3.16M | 3.16M |
| Cash from Financing | -9.49M | 4.77M | 12.77M | 8.73M | 8.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.28M | -18.32M | -14.98M | -23.55M | -25.86M |